which we described available data relating to clinical features at presentation only [1] ; and our report of 4 fatal cases [2] . We have, therefore, undertaken a detailed, systematic, prospective study of the presentation and clinical course of patients with a diagnosis of confirmed acute knowlesi malaria.
PATIENTS AND METHODS
Study site. This prospective study was conducted in the Kapit Division, which has a total population of 109,000 people of mostly Iban ethnicity [1] . A single World Health Organization (WHO) level 2 hospital serves the Division, together with 3 polyclinics and 22 rural health clinics. Health policy mandates that all patients with malaria are hospitalized until negative blood smear results are obtained on 2 consecutive days. Treatment for malaria is provided free of charge.
Subjects. Recruitment was consecutive and took place during 2 periods totalling 17 months from July 2006 through February 2008. All nonpregnant patients aged у15 years who were admitted to Kapit Hospital with a blood film result positive for any Plasmodium species were eligible, provided that there was no significant comorbid disease and that they had taken no antimalarial treatment within the previous 14 days. Subsequent confirmation of malaria species was determined by nested polymerase chain reaction assays [1] . All patients provided witnessed informed consent to the study procedures, which were approved by the Medical Research Ethics Subcommittee of the Malaysian Ministry of Health. In an initial 2-month pilot study, most cases of P. vivax and P. falciparum infection were among logging camp workers returning from long periods in Oceania or Equatorial Africa, respectively. Because the demographic characteristics and background immunity of these patients were significantly different from those of patients with knowlesi malaria, their clinical and laboratory data are presented but are not compared directly with data for patients with P. knowlesi infection.
Clinical procedures. Detailed demographic characteristics, history, and examination findings were recorded on a standard form. A baseline blood sample was obtained for routine biochemical and hematological testing, and regular monitoring of temperature, blood pressure, and pulse rate was started. Treatment was administered promptly according to the Malaysian Ministry of Health Guidelines. Because there are no current guidelines for P. knowlesi malaria, the guidelines for P. malariae were used. Patients with uncomplicated knowlesi malaria received oral chloroquine (25 mg base/kg over a 3-day period) followed by primaquine (15 mg daily for 2 days) given as a gametocidal agent. Oral and/or intravenous hydration was administered at the discretion of the treating physician. Patients presenting with or developing features of severe malaria were treated in accordance with WHO guidelines [11] except that the thresholds for hyperparasitemia and anemia were changed to 1100,000 asexual forms/mL of whole blood and !7.1 g of hemoglobin/dL, respectively, to allow for the low immunity levels of the local population. If indicated clinically, patients were transferred to Sibu Hospital for intensive care.
All patients were assessed clinically and by microscopic examination of blood films on each inpatient day. Additional laboratory tests were performed as indicated by the clinical state of the patient. Parasite clearance time and fever clearance time were taken as the number of days to the first of at least 2 followup assessments at which the patient had negative blood film results and was afebrile, respectively. When the patient was afebrile and had negative blood film results for 2 consecutive days, additional blood samples were obtained for routine biochemical and hematological tests before discharge. Patients returned on the 28th day after hospital admission for clinical review and blood tests.
Laboratory procedures. All blood films were examined by 2 experienced microscopists. The parasite density was first determined at Kapit Hospital on the basis of the number of parasites per 500 white blood cells and the total white blood cell count for each patient. Microscopic examination was repeated in Kuching, with the second microscopist blinded to the initial result. The mean of the 2 parasite densities was used in data analysis. Parasite DNA was extracted from blood spots that had been collected on filter paper, and the Plasmodium species was determined by nested polymerase chain reaction for P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi, as described elsewhere [1, 12] .
Hematological profiles were determined on site using semiautomated methods (Sysmex model KX-21N). Serum sodium, potassium, glucose, creatinine, bilirubin, alanine aminotransferase (ALT), and albumin levels were either assayed on site (AVL 9180 and Hitachi 902; Roche/Hitachi, Roche Diagnostics) or serum samples were stored at Ϫ80ЊC before transfer on dry ice to the Biochemistry Department, Fremantle Hospital (Freemantle, Australia), for analysis (Cobas Integra 800; Roche Diagnostics). An additional uncuffed blood sample was collected into a chilled fluoride-oxalate tube, centrifuged immediately and separated plasma stored at Ϫ80ЊC before transfer on dry ice to Fremantle Hospital for plasma lactate assay (COBAS INTEGRA 800). Other laboratory investigations, including blood cultures, urine dipstick testing, microscopic examination, and chest radiography were performed as indicated clinically.
Statistical analysis. Data were analyzed using SPSS software, version 15.0 (SPSS). Normally distributed variables were compared using the Student's t test or analysis of variance and the Scheffé post hoc test. All other data were analyzed using nonparametric methods (the Wilcoxon rank-sum test or Friedman test). Proportions were compared with use of Fisher's exact test. Multiple logistic or linear regression analysis using forward conditional modeling was performed to determine baseline associates of complications or markers of severity, respectively. Plausible predictive variables with a statistically significant ( ) univariate association with the specific severity out-P ! .05 come were selected for inclusion in the model. These variables were log-transformed prior to model entry if they were nonnormally distributed and a stepwise forward selection procedure was then performed to identify the significant independent associates in each case.
RESULTS
Baseline characteristics. The number of patients who participated in the study in relation to all malaria admissions to Kapit Hospital during the recruitment period is shown in figure  1 . Their baseline demographic and clinical features are summarized in table 1. P. knowlesi infections were acquired locally by both sexes and across all age groups, with 93 (87%) of patients reporting recent activities in the jungle or forest-fringe in the Kapit Division. All regions along the Rejang River and its associated tributaries were represented, and there was no significant clustering of cases. Confirming our pilot study findings, most of the cases of vivax and falciparum malaria (31 cases; 69%) were imported, and the numbers were relatively small.
The overall median duration of symptoms prior to hospitalization was 5 days (interquartile range, 3-5 days), but 2 patients were unwell for 110 days before hospitalization. Symptoms were typically nonspecific. Fever and chills were present in almost all cases, and other frequent symptoms included abdominal pain, breathlessness, and productive cough. Tachypnea, pyrexia, and tachycardia were common clinical signs (table 1).
The results of baseline laboratory investigations are summarized in table 2. The level of parasitemia at hospital admission was relatively low in the P. knowlesi group, but there was a wide range that included 3 patients (2.8%) with parasite densities 1100,000 parasites/mL and 33 patients (30.8%) with densities !500 parasites/mL. The most common abnormal laboratory finding was thrombocytopenia (!150,000 platelets/mL), which was present in 104 patients (98%), with 31 (29%) of 107 patients having a platelet count !50,000 platelets/mL. The 3 patients who did not have thrombocytopenia (155,000, 152,000, and 167,000 platelets/mL) had low parasitemias (5, 126, and 170 asexual forms/mL, respectively), and all became thrombocytopenic within 24 h (with nadir values of 90,000, 131,000, and 112,00 platelets/mL, respectively). Lymphopenia was found in 7 (6.5%) of patients at presentation, but all patients had normal values by the time of hospital discharge. Anemia was uncommon at hospital admission. Only 5 (4.6%) of the patients had a hemoglobin concentration !10 g/dL, whereas none of the patients met the criteria for severe anemia. Mild hepatic dysfunction, usually comprising an elevated serum ALT level and a low serum albumin level, was relatively common. Mildto-moderate hyponatremia (range, 122-135 mmol/L) was evident in 29% of cases, all of which responded to rehydration and antimalarial therapy. On the basis of WHO criteria for severe falciparum malaria [11] , 8 (7.5%) of the patients with P. knowlesi infection had severe infections at presentation (table 3) . The most frequent clinical presentations of severe infection were respiratory distress (diagnosed in 4 patients on the basis of a respiratory rate creatinine level у265 mmol/L despite fluid resuscitation), 2 cases of hypotension (systolic blood pressure р80 mmHg despite fluid resuscitation), and 1 case of hypoglycemia (venous plasma glucose level !2.2 mmol/L). There were no cases of unrousable coma. A combination of features was present at hospital admission in 3 patients.
Clinical course. Clinical and parasitological outcomes together with changes in key hematological and biochemical variables during hospitalization and at day 28 for patients with knowlesi malaria are summarized in tables 4 and 5. There was no clinical, laboratory, or radiological evidence of other infections or conditions at study entry, during hospitalization, or at follow-up that would have influenced outcome. When patients with knowlesi malaria were discharged from the hospital, platelet counts had increased, and all patients had values that were within the normal range by day 28. Most of the remaining hematological and biochemical parameters had improved by hospital discharge. Abnormal laboratory values had resolved in all 87 patients with knowlesi malaria who attended for day 28 review.
Three patients, including 2 patients without complications at hospital admission, developed respiratory distress (table 3) . A total of 7 (6.5%) of the 107 patients in the knowlesi group, all of whom were female, presented with or developed respiratory distress. Of those patients with evidence of severe knowlesi malaria either at presentation or during treatment, 2 died (table 3). Patient 1 had parasitemia at presentation (parasite density, 222,570 parasites/mL), evidence of multiorgan failure, hypoglycemia, and lactic acidosis. This patient died within 6 h after hospital admission despite intensive treatment with intravenous quinine, broad spectrum antibiotics, and ionotropic and ventilatory support. Patient 8 presented with symptoms and signs of a right hemiparesis and sensory inattention and had a history of uncontrolled hypertension. The patient's parasite density at hospital admission was 214,000 parasites/mL. She was treated with intravenous quinine but developed respiratory distress that required mechanical ventilation. After showing signs of improvement, she experienced neurological deterioration on the seventh day of hospitalization and died 24 h later. No neuroimaging studies were possible. Baseline P. knowlesi parasitemia, complications, and markers of severity. Patients reporting breathlessness or vomiting had greater geometric mean parasite counts than did those who did not report these symptoms ( and , P p .025 P p .038 respectively). In a logistic regression model, presentation with or development of respiratory distress was positively and independently associated with the admission ln(parasitemia) and inversely associated with the admission hemoglobin level (P p and , respectively). In multiple linear regression, .004 P p .015 (1) ln(parasitemia) and age were independent positive associates of ln(admission serum creatinine) ( and , P ! .001 P p .007 respectively), (2) ln(parasitemia) and ln(plasma glucose) were independent associates of ln(admission serum total serum bilirubin) ( and , respectively), and (3) ln(par-P p .003 P p .008 asitemia) was an independent associate of the ln(admission platelet count) and absolute differences between day 28 and hospital admission platelet counts ( and , re-P p .002 P p .004 spectively). In other multivariate models, ln(parasitemia) was not an independent associate of the admission hemoglobin level ( ) or serum ALT level ( ). In receiver operating P p .49 P p .70 characteristic curve analysis, parasitemia was a good predictor of complications after excluding hyperparasitemia (area under the receiver operating characteristic curve, 0.90 [95% confidence interval, 0.82-0.98]; ). The prespecified 100,000/ P ! .001 mL threshold was highly specific (specificity, 100%) but had a sensitivity of 30%.
DISCUSSION
The present study provides the first detailed, prospective evaluation of P. knowlesi infection in an area of Malaysian Borneo in which it is the most common locally acquired human malaria. Although there were demographic differences between the 3 groups of patients with malaria, there were no presenting symptoms or signs that distinguished knowlesi malaria from either falciparum or vivax malaria. Consistent with availablealbeit, incomplete-retrospective data [1, 2] , most cases of knowlesi malaria were uncomplicated and responded promptly to treatment with chloroquine and primaquine, but complications developed in nearly 1 in 10 patients. Because the number of cases of severe knowlesi malaria was small, an accurate case fatality rate is difficult to ascertain, but the case fatality rate was 1.8% (95% confidence interval, 0.2%-6.6%) in our sample. Malaria may have been a contributory factor rather than the sole cause in our patient who presented with a stroke. Nevertheless, P. knowlesi infections occur in older as well as younger adult patients in the Kapit Division, and the vital organ dysfunction caused by this parasite may unmask underlying significant comorbidities.
Despite the significantly lower peripheral blood parasitemia, the patients with knowlesi malaria had clinical and laboratory profiles that were largely similar to those for patients with P. 
NOTE.
Severe malaria was defined on the basis of World Health Organization criteria for severe falciparum malaria [11] . Hyperparasitemia was defined as 1100,000 parasites/mL. Severe anemia was defined as hemoglobin concentration !7.1 g/dL. Hypotension was defined as systolic blood pressure р80 mmHg; Acute renal impairment was defined as a serum creatinine level 1265 mmol/L despite rehydration. Jaundice was defined as serum bilirubin level 143 mmol/L. Hypoglycemia was defined as a serum glucose level !2.2 mmol/L. Hyperlactaemia was defined as a lactate level 16 .0 mmol/L. Acute pulmonary edema or respiratory distress was defined as a respiratory rate 130 breaths/min plus oxygen saturation !94% on room air and/or pulmonary infiltrates visible on a chest radiograph. falciparum and P. vivax infection, with a wide spectrum of illness. The most frequent complication in our cohort was respiratory distress, which affected 1 in 15 patients. It is also a relatively common sequelum of severe falciparum malaria [13] . Respiratory distress can reflect pulmonary edema, acute respiratory distress syndrome, or metabolic acidosis. In our group, a pulmonary, rather than metabolic, etiology was the main cause, because we measured blood lactate concentrations and had access to chest radiographs and pulse oximetry. The strong association between parasitemia at hospital admission and the development of respiratory distress in our patients suggests that parasite-specific effects that increase pulmonary capillary permeability rather than iatrogenic fluid overload or the syndrome of inappropriate anti-diuretic hormone secretion are responsible, as in falciparum malaria [14] . Patients with falciparum malaria who develop respiratory distress have a relatively poor prognosis [13] , and both of our patients who died developed this complication. Respiratory distress has also been reported as a rare complication of vivax [15] [16] [17] and ovale [18, 19] malaria. We cannot explain the disproportionate number of female patients with this complication in the P. knowlesi group.
Although the women in our cohort, compared with the men, had lower serum albumin concentrations at presentation (34.5 g/L vs 38.0 g/L;
), sex association has not been reported P ! .001 in the case of the other human malarias and is likely to be attributable to the play of chance in the present study.
The P. knowlesi parasitemia at hospital admission was also strongly and independently associated with renal dysfunction, and 3 patients developed renal failure despite resuscitation and rehydration. As with respiratory distress, this is another complication of falciparum malaria that could be mediated by the parasite [20] , although the microvascular sequestration that may contribute to P. falciparum-associated renal dysfunction [21] is not known to occur in P. knowlesi infection. The presence of P. knowlesi parasitemia at hospital admission was also independently associated with the total serum bilirubin but not serum ALT level. This could reflect relatively brisk hemolysis associated with the short (24-h) erythrocytic cycle rather than abnormal liver function, but the median parasitemia was low, and there was no inverse association with hemoglobin level at hospital admission. It is still possible that hepatic dysfunction is a relatively late vital organ complication of P. knowlesi malaria but-as evidenced by patient 1, who presented with jaundice, hypoglycemia, and lactic acidosis-it is one with potentially devastating metabolic consequences.
Consistent with the nonsequestering nature of P. knowlesi, we did not observe significant neurologic sequelae except in patient 8, who had evidence of a stroke in the context of preexisting cerebrovascular risk. In addition, in contrast with the group of patients with P. falciparum infection, the group of patients with P. knowlesi included no patients with severe anemia. Both severe anemia and neurologic disturbance have been reported recently as common manifestations of severe vivax malaria [22, 23] , but these complications were observed in patients who were younger than those in the present study and in areas of much greater malaria transmission of multiple Plasmodium species.
Despite the very high prevalence of thrombocytopenia among our patients with P. knowlesi infection (100%, compared with !80% in other human malarias [24] [25] [26] ), none had a clinically evident coagulopathy. This is consistent with the relative infrequency of bleeding episodes complicating severe falciparum malaria [11] , but it is possible that a low platelet count (52,000 platelets/mL) and prolonged prothrombin time (17 sec) contributed to an intracerebral hemorrhage in the patient with knowlesi malaria who died of a probable stroke. The almost invariable presence of thrombocytopenia could facilitate diagnosis of knowlesi malaria. In addition, the significant association between platelet count and P. knowlesi parasite density and, in turn, the relationship between parasitemia and markers of severity, could imply that very low platelet counts are of prognostic significance. Such a relationship has been found among African children with falciparum malaria [27] .
Although our study included relatively few patients with severe knowlesi malaria, we provide preliminary data relating to the incidence of severe disease. A larger study on the main complications and pathophysiology of knowlesi malaria is in progress, with the aim of establishing specific criteria for severity. It is likely that those for severe falciparum malaria, including neurologic sequelae, severe anemia, and hyperparasitemia [11] , may not adequately address the unique biologic properties of P. knowlesi. In the case of falciparum malaria, у250,000 parasites/mL (or 5% parasitized erythrocytes) is conventionally used [11] , but thresholds as low as 100,000/mL have been associated with increased mortality and have been used for nonimmune patients [28, 29] . It is therefore important to determine knowlesi-specific markers of disease severity, especially an accurate risk-associated threshold parasitemia.
Our study shows that knowlesi malaria is a significant cause of morbidity in the Kapit Division, extends available data to characterize the spectrum of illness and its clinical course, and confirms our previous observation that life-threatening complications can supervene [2] . Knowlesi malaria is widely distributed in Southeast Asia; it affects mainly people who enter forests or the forest fringe, but the transmission ecology of this potentially serious disease may be changing [30] . Recently, European travellers to Malaysia have received a diagnosis of knowlesi malaria following their return home [31, 32] . The increase in tourism in Southeast Asia may mean that more cases are detected in the future, including in Western countries. Clinicians assessing a patient who has visited an area with known or possible P. knowlesi transmission should be aware of the diagnosis, its clinical manifestations, and its course.
